- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Browse
Administrators only